Search

everythinglearnresearchcommunity

for

Search:↓

Hormones significantly affect hair growth and loss, requiring personalized treatment.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Women over forty can maintain skin and hair health with lifestyle and dietary changes.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Estrogen affects scalp cell types differently, enhancing some wound healing processes.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Androgens and other hormones affect hair growth and skin conditions like acne.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.